Recursion Pharmaceuticals, Inc. (RXRX)

Last Three Months

29-Jan-24 -- 28-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

12

0

4

+1

0

+2

0

+3

Two Year Chart

29-Apr-22 -- 28-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
03-Apr-24 5:42 PM View:	01-Apr-24 Grant 0	Burrell Terry-Ann Director		Recursion Pharmaceuticals, Inc. - RXRX	3% 54.85K to 56.31K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 5:43 PM View:	01-Apr-24 Grant 0	Chavez R Martin Phd Director		Recursion Pharmaceuticals, Inc. - RXRX	3% 58.08K to 60.08K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 5:43 PM View:	01-Apr-24 Grant 0	Dar Zavain Director		Recursion Pharmaceuticals, Inc. - RXRX	2% 87.59K to 89.06K	0	0	--	--	Show Txns Hide Txns

25-Mar-24 6:39 PM View:	21-Mar-24 Planned Option Sale ($85.98K)	Larson Tina Marriott President and COO		Recursion Pharmaceuticals, Inc. - RXRX	54% 414.55K to 639.98K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 5:43 PM View:	01-Apr-24 Grant 0	Li Dean Y Director		Recursion Pharmaceuticals, Inc. - RXRX	0% 3.17M to 3.17M	0	0	--	--	Show Txns Hide Txns

18-Apr-24 5:12 PM View:	17-Apr-24 Planned Option Sale ($175.35K)	Secora Michael Chief Financial Officer		Recursion Pharmaceuticals, Inc. - RXRX	25% 981.01K to 1.23M	0	0	--	--	Show Txns Hide Txns

18-Apr-24 5:12 PM View:	16-Apr-24 Sale (Planned) ($87.73K)	Borgeson Blake Director		Recursion Pharmaceuticals, Inc. - RXRX	(1%) 7.32M to 7.23M	0	0	--	--	Show Txns Hide Txns

05-Apr-24 5:44 PM View:	04-Apr-24 Sale (Planned) ($225.50K)	Gibson Christopher Chief Executive Officer Director		Recursion Pharmaceuticals, Inc. - RXRX	19% 791.73K to 938.52K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 7:03 PM View:	09-Feb-24 Payment of Exercise ($19.09K)	Mauro David J Chief Medical Officer		Recursion Pharmaceuticals, Inc. - RXRX	28% 190.71K to 244.63K	0	0	--	--	Show Txns Hide Txns